+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pancreatic Cancer Treatment Market Size, Share & Trends Analysis By Type, By Treatment, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 153 Pages
  • December 2024
  • Region: Global
  • Grand View Research
  • ID: 5998873
Description Jump to:

Pancreatic Cancer Treatment Market Growth & Trends

The global pancreatic cancer treatment market size is anticipated to reach USD 5.84 billion by 2030. The market is projected to grow at a CAGR of 12.30% from 2025 to 2030. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

Pancreatic Cancer Treatment Market Report Highlights

  • The study suggests that exocrine cancer is by far the most common type of pancreatic cancer accounting for more than 95% of the overall pancreatic cancer types.
  • Among the treatment types, targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells.
  • North America dominated the segment with the largest revenue share in 2024 due to high adoption rate of advanced treatment options and highly developed healthcare infrastructure.
  • Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, growing awareness regarding the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pancreatic Cancer Treatment Market Variables, Trends, & Scope
3.1. Parent Market Outlook
3.2. Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Rising Prevalence of Pancreatic Cancer Globally
3.3.1.2. Advancements in Modern Therapeutics
3.3.1.3. Growing Investments in Pancreatic Cancer R&D
3.3.2. Market Restraints Analysis
3.3.2.1. High Cost of Advanced Therapies
3.3.2.2. Stringent Regulatory and Reimbursement Challenges
3.4. Pancreatic Cancer Treatment Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Pancreatic Cancer Treatment Market: By Type Estimates & Trend Analysis
4.1. Pancreatic Cancer Treatment Market: Type Segment Dashboard
4.2. Pancreatic Cancer Treatment Market: By Type Movement Analysis, USD Million, 2024 & 2030
4.3. Exocrine
4.3.1. Exocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Endocrine
4.4.1. Endocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pancreatic Cancer Treatment Market: Treatment Estimates & Trend Analysis
5.1. Pancreatic Cancer Treatment Market: Treatment Segment Dashboard
5.2. Pancreatic Cancer Treatment Market: By Treatment Movement Analysis, USD Million, 2024 & 2030
5.3. Chemotherapy
5.3.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Radiation Therapy
5.4.1. Radiation Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pancreatic Cancer Treatment Market: Distribution Channel Estimates & Trend Analysis
6.1. Pancreatic Cancer Treatment Market: Distribution Channel Segment Dashboard
6.2. Pancreatic Cancer Treatment Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
6.3. Hospital Pharmacies
6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Pharmacies
6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pancreatic Cancer Treatment Market: Regional Estimates & Trend Analysis
7.1. Pancreatic Cancer Treatment Market Share, By Region, 2024 & 2030, USD Million
7.2. North America
7.2.1. North America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018- 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Sweden Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. Kuwait
7.6.4.1. Kuwait Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Africa
7.6.5.1. South Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Accuray Incorporated
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. AstraZeneca
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Novartis AG
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Pfizer Inc.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Bristol-Myers Squibb Company
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Ipsen Pharma
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Eli Lilly and Company
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Siemens Healthineers AG (Varian Medical Systems, Inc., part of the company)
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Elekta AB
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 4 Global pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 5 Global pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 6 North America pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
Table 7 North America pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 8 North America pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 9 North America pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 U.S. pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 11 U.S. pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 12 U.S. pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Canada pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 14 Canada pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 15 Canada pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Mexico pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 17 Mexico pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 18 Mexico pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 19 Europe pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
Table 20 Europe pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 21 Europe pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 22 Europe pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 23 Germany pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 24 Germany pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 25 Germany pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 26 UK pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 27 UK pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 28 UK pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 29 France pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 30 France pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 31 France pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Italy pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 33 Italy pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 34 Italy pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Spain pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 36 Spain pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 37 Spain pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Denmark pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 39 Denmark pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 40 Denmark pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Sweden pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 42 Sweden pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 43 Sweden pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Norway pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 45 Norway pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 46 Norway pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Asia Pacific pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 50 Asia Pacific pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 51 China pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 52 China pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 53 China pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 54 Japan pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 55 Japan pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 56 Japan pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 57 India pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 58 India pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 59 India pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 South Korea pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 61 South Korea pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 62 South Korea pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Australia pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 64 Australia pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 65 Australia pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Thailand pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 67 Thailand pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 68 Thailand pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 69 Latin America pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
Table 70 Latin America pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 71 Latin America pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 72 Latin America pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Brazil pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 74 Brazil pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 75 Brazil pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Argentina pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 77 Argentina pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 78 Argentina pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 83 South Africa pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 84 South Africa pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 85 South Africa pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 89 UAE pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 90 UAE pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 91 UAE pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Kuwait pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
Table 93 Kuwait pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
Table 94 Kuwait pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Pancreatic Cancer Treatment Market Segmentation
Fig. 8 Market Snapshot, 2024
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Pancreatic cancer treatment market: Type movement analysis
Fig. 16 Pancreatic cancer treatment market: Type outlook and key takeaways
Fig. 17 Exocrine pancreatic cancer treatment market estimates and forecasts, 2018 - 2030
Fig. 18 Endocrine pancreatic cancer treatment market estimates and forecasts, 2018 - 2030
Fig. 19 Pancreatic cancer treatment market: Treatment movement analysis
Fig. 20 Pancreatic cancer treatment market: Treatment outlook and key takeaways
Fig. 21 Chemotherapy market estimates and forecasts, 2018 - 2030
Fig. 22 Radiation Therapy market estimates and forecasts, 2018 - 2030
Fig. 23 Others market estimates and forecasts, 2018 - 2030
Fig. 24 Pancreatic cancer treatment market: Distribution Channel movement analysis
Fig. 25 Pancreatic cancer treatment market: Distribution Channel outlook and key takeaways
Fig. 26 Hospital Pharmacies market estimates and forecasts, 2018 - 2030
Fig. 27 Retail Pharmacies market estimates and forecasts, 2018 - 2030
Fig. 28 Others market estimates and forecasts, 2018 - 2030
Fig. 29 Regional Marketplace: Key Takeaways
Fig. 30 Regional Outlook, 2024 & 2030
Fig. 31 Global Pancreatic Cancer Treatment Market, Region Movement Analysis
Fig. 32 North America pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 33 U.S. pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 34 Canada pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 35 Mexico pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 36 Europe pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 37 Germany pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 38 UK pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 39 France pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 40 Italy pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 41 Spain pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 42 Denmark pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 43 Sweden pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 44 Norway pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 46 Japan pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 47 China pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 48 India pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 49 Australia pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 50 South Korea pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 51 Thailand pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 52 Latin America pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 53 Brazil pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 54 Argentina pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 55 Middle East and Africa pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 56 South Africa pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 58 UAE pancreatic cancer treatment market, 2018 - 2030 (USD Million)
Fig. 59 Kuwait pancreatic cancer treatment market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Accuray Incorporated
  • AstraZeneca
  • Novartis AG
  • Pfizer Inc.
  • Genentech, Inc. (F. Hoffmann-La Roche Ltd)
  • Bristol-Myers Squibb Company
  • Ipsen Pharma
  • Eli Lilly and Company
  • Siemens Healthineers AG (Varian Medical Systems, Inc., part of the company)
  • Elekta AB

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages153
PublishedDecember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.92 billion
Forecasted Market Value ( USD ) by 2030 $ 5.84 billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pancreatic Cancer Treatment Market by Affected region, Type - Global Forecast 2025-2030 - Product Image

Pancreatic Cancer Treatment Market by Affected region, Type - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Pancreatic Cancer Therapeutics Market by Type, Product, End-Use - Global Forecast 2025-2030 - Product Image

Pancreatic Cancer Therapeutics Market by Type, Product, End-Use - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Pancreatic Cancer Market - Product Image

Pancreatic Cancer Market

  • Report
  • 200 Pages
  • Global
From
Pancreatic Cancer Drugs - Global Strategic Business Report - Product Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • 151 Pages
  • Global
From
Pancreatic Cancer Drugs Global Market Report 2024 - Product Image

Pancreatic Cancer Drugs Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.